Zinc: An Essential Micronutrient
Am Fam Physician. 2009 May 1;79(9):768-772.
Zinc is an essential micronutrient for human metabolism that catalyzes more than 100 enzymes, facilitates protein folding, and helps regulate gene expression. Patients with malnutrition, alcoholism, inflammatory bowel disease, and malabsorption syndromes are at an increased risk of zinc deficiency. Symptoms of zinc deficiency are nonspecific, including growth retardation, diarrhea, alopecia, glossitis, nail dystrophy, decreased immunity, and hypogonadism in males. In developing countries, zinc supplementation may be effective for the prevention of upper respiratory infection and diarrhea, and as an adjunct treatment for diarrhea in malnourished children. Zinc in combination with antioxidants may be modestly effective in slowing the progression of intermediate and advanced age-related macular degeneration. Zinc is an effective treatment for Wilson disease. Current data do not support zinc supplementation as effective for upper respiratory infection, wound healing, or human immunodeficiency virus. Zinc is well tolerated at recommended dosages. Adverse effects of long-term high-dose zinc use include suppressed immunity, decreased high-density lipoprotein cholesterol levels, anemia, copper deficiency, and possible genitourinary complications.
Zinc is the second most abundantly distributed trace element in the body after iron.1 Zinc catalyzes enzyme activity, contributes to protein structure, and regulates gene expression.2 It is found in a variety of foods, such as beef, poultry, seafood, and grains.2,3 Commercial zinc supplements contain 7 to 80 mg of elemental zinc, and are commonly formulated as zinc oxide or salts with acetate, gluconate, and sulfate. In the 2002 National Health Interview Survey, 2.5 percent of adults reported using zinc supplements in the previous year.4 Multivitamins were used by 62 percent of adults and contain 7.5 to 15 mg of elemental zinc.4 Zinc supplements are commonly used to alleviate a number of conditions, including zinc-deficient states, diarrhea, age-related macular degeneration, upper respiratory infection (URI), wound healing, and human immunodeficiency virus (HIV).
Zinc is absorbed in the small intestine. Prolonged, severe decreases or increases in zinc intake are necessary to substantially affect zinc stores.5 Zinc is a cofactor for polymerases and proteases involved in many cellular functions (e.g., wound repair,6 intestinal epithelial cell regeneration).7 Zinc is also a cofactor for thymulin, a thymic hormone essential for T-cell maturation.8 Zinc has antioxidant properties and may protect against macular degeneration from oxidative stress.9
SORT: KEY RECOMMENDATIONS FOR PRACTICE
SORT: KEY RECOMMENDATIONS FOR PRACTICE
|Clinical recommendation||Evidence rating||References|
Zinc reduces the severity and duration of acute and chronic diarrhea in children from developing countries.
Zinc acetate is an effective maintenance therapy for Wilson disease.
Clinical zinc deficiency in adults should be treated with zinc supplements at two to five times the recommended dietary allowance.
Zinc in combination with vitamins C and E, and beta-carotene may slow the progression of intermediate and advanced age-related macular degeneration.
A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to http://www.aafp.org/afpsort.xml.
Uses and Effectiveness
Zinc deficiency caused by malnutrition is the 11th major risk factor in the global distribution of disease burden and is associated with 1.8 million deaths annually.10 Serum zinc levels are not a reliable measure of zinc stores and, therefore, are not recommended for routine screening. A presumptive diagnosis of zinc deficiency can be made in the context of zinc-deficiency symptoms, signs of malnutrition (e.g., underweight, hypoalbuminemia), or conditions commonly associated with zinc deficiency (Table 1).1,2 A meta-analysis of 33 randomized controlled trials (RCTs) enrolling prepubertal children from North and South America, Europe, Africa, and Asia who were at risk of zinc deficiency showed that zinc supplementation modestly enhanced linear growth and weight gain (effect sizes of 0.35 and 0.31, respectively) compared with the control group.11
Table 1 Characteristics of Zinc Deficiency
Characteristics of Zinc Deficiency
Crohn disease, celiac disease, chronic alcoholism, cirrhosis, sickle cell disease, acrodermatitis enteropathica
Pregnancy, lactation, prolonged intravenous feeding, vegan diet, short bowel syndrome, history of intestinal surgery (e.g., gastric bypass)
A meta-analysis of 22 RCTs of zinc supplements versus placebo for the treatment of diarrhea in children from developing countries found an 18 percent reduction of diarrhea symptoms compared with placebo.12 A meta-analysis of 15 prevention studies demonstrated that zinc supplementation conferred a 14 percent reduced risk in the incidence of diarrheal episodes compared with placebo.13 It is uncertain if zinc's effect on diarrhea is because of an independent effect or repletion of zinc deficiency. No data are available for zinc and childhood diarrhea in industrialized countries.
AGE-RELATED MACULAR DEGENERATION
The evidence supporting zinc and antioxidants for slowing the progression of age-related macular degeneration comes predominantly from the Age-Related Eye Disease Study (AREDS).14,15 AREDS randomized 3,640 mostly well-nourished adults 55 to 80 years of age with age-related macular degeneration to oral zinc oxide, antioxidants (vitamin C, vitamin E, beta-carotene), zinc plus anti-oxidants, or placebo. For participants with intermediate age-related macular degeneration (i.e., many medium-sized drusen or at least one large drusen) or advanced age-related macular degeneration (i.e., breakdown of light-sensitive cells and support tissues with or without blood vessel fragility and edema [“wet” or “dry” age-related macular degeneration, respectively]), the zinc plus antioxidant group had a modest reduced risk of worsening visual acuity compared with placebo (27 percent, P = .008). However, there were increased hospitalizations because of urinary tract infections and nephrolithiasis in the two zinc arms versus non-zinc arms (11.1 versus 7.6 percent; P = .003).16 It would be prudent for smokers at risk of advanced age-related macular degeneration to refrain from taking the beta-carotene component because of the increased risk of lung cancer in smokers taking this supplement.17 The value of zinc plus antioxidants is unknown in persons younger than 55 years, those with a family history of age-related macular degeneration, and those with a different nutritional status.
There are no published RCTs addressing zinc for the primary prevention of early age-related macular degeneration.18 Results of prospective cohort studies are mixed. A meta-analysis of four such studies found an odds ratio of 0.91 (95% confidence interval [CI], 0.74 to 1.11) for the association between high zinc intake and early age-related macular degeneration.19 A subsequent cohort study found the highest decile of zinc intake for Australian adults to be associated with a 44 percent reduction in the risk of age-related macular degeneration.20
A meta-analysis including 12 RCTs with a total of 5,512 children in developing countries found a reduction in URI incidence in those using zinc supplements compared with placebo (8 percent; 95% CI, 1 to 15 percent).13 Regarding treatment, a meta-analysis of eight RCTs with 890 predominantly adult participants with URI in industrialized countries who were treated with zinc lozenges found no evidence of a statistically significant reduction in duration.21 Methodologic problems included poor blinding, small sample size, high drop-out rates, and variability in zinc dosage and formulation. Subsequent studies in adults22–25 and children26,27 showed similarly mixed results. Overall, robust data are lacking for the effectiveness of zinc lozenges in reducing the duration or severity of URI.
Zinc deficiency is associated with impaired wound healing.28 Although zinc is a common ingredient in topical products used to treat skin conditions such as ulcers, diaper rash, and hemorrhoids, relatively few studies support its use for accelerating wound healing. An RCT of 46 infants with diaper dermatitis found no significant difference in resolution between zinc oxide ointment and ointment base alone.29 A meta-analysis of 181 participants from six RCTs of oral zinc sulfate versus placebo for venous or arterial leg ulcers found no significant difference in time to ulcer resolution.30 An RCT comparing surgical mesh impregnated with zinc oxide ointment versus mesh with ointment base alone found no statistically significant difference in time to secondary closure of pilonidal surgery wounds.31
Zinc deficiency is associated with the rapid progression of HIV.32 However, most RCTs of zinc in persons who are HIV positive have shown no increase in CD4 cell counts or decrease in viral load.33,34 Wilson disease can be successfully treated with zinc because of its ability to compete with copper for binding sites.35 Zinc acetate has been shown to be effective in the long-term treatment of Wilson disease and is approved by the U.S. Food and Drug Administration for maintenance therapy.36 Although oral zinc has been used for acne, minocycline (Dynacin) is twice as effective.37
Contraindications, Adverse Effects, and Interactions
Chronic ingestion of zinc supplements up to the tolerable upper intake level (40 mg elemental zinc per day in adults) is generally considered safe. Use of zinc supplements above the tolerable upper intake level in well-nourished pregnant and lactating women is contraindicated.2 Common adverse effects of excessive zinc intake include metallic taste, nausea, vomiting, abdominal cramping, and diarrhea (Table 2).2 Prolonged exposure to amounts greater than the tolerable upper intake level may suppress immunity, decrease high-density lipoprotein cholesterol levels, and cause hypochromic microcytic anemia and copper deficiency.38 Furthermore, the Health Professionals Follow-up Study of 46,974 adult men found a 2.3 increased relative risk of advanced prostate cancer in men using elemental zinc in amounts of 100 mg per day or more.39 Zinc may inhibit absorption of penicillamine (Cuprimine), tetracyclines, and quinolones. Iron supplements and phytates, found in grains and legumes, can inhibit zinc absorption and should be taken at least two hours apart from zinc supplements.
Table 2 Key Points About Zinc Supplements
Key Points About Zinc Supplements
Probably effective: zinc deficiency; Wilson disease
Possibly effective: slow progression of age-related macular degeneration; childhood diarrhea and URI in developing countries
Probably ineffective: URI, wound healing, human immunodeficiency virus
Metallic taste, nausea, vomiting, abdominal cramping, diarrhea, suppressed immunity, reduced levels of high-density lipoprotein cholesterol, decreased copper stores, urinary tract infection, nephrolithiasis
Penicillamine (Cuprimine), tetracyclines, quinolones; decreased copper absorption
Use with caution in pregnant and lactating women
Zinc deficiency: two to five times the recommended dietary allowance† (depending on severity) for six months
Diarrhea: 5 to 20 mg
Age-related macular degeneration: 80 mg of elemental zinc with 2 mg of copper, 500 mg of vitamin C, 400 IU of vitamin E, 15 mg of beta-carotene
Dose should not exceed the tolerable upper intake level‡ for prolonged periods
$4 to 15 for three-month supply
Safe at doses less than or equal to the tolerable upper intake level‡; useful for zinc deficiency, Wilson disease, and childhood diarrhea in malnourished populations; possibly useful in combination with antioxidant supplements for slowing the progression of age-related macular degeneration
URI = upper respiratory infection.
*— All doses are for milligrams of elemental zinc per day.
†— Recommended dietary allowance 2 (by age) = 0 to 6 months: 2 mg; 7 months to 3 years: 3 mg; 4 to 8 years: 5 mg; 9 to 13 years: 8 mg; 14 to 18 years: 11 mg (boys), 8 mg (girls); older than 19 years: 11 mg (men), 8 mg (women); pregnancy: 11 mg; lactation: 12 mg.
‡— Tolerable upper intake level per day 2 (by age) = 0 to 6 months: 4 mg; 7 to 12 months: 5 mg; 1 to 3 years: 7 mg; 4 to 8 years: 12 mg; 9 to 13 years: 23 mg; 14 to 18 years: 34 mg; older than 18 years: 40 mg.
Mild zinc deficiency should be treated with zinc supplementation at two to three times the recommended dietary allowance (RDA), whereas moderate to severe deficiency can be treated at four to five times the RDA.40,41 Treatment should last for six months. For acute diarrhea in malnourished children six to 36 months of age, 20 mg per day of elemental zinc has been used.12 To slow the progression of age-related macular degeneration, 80 mg of elemental zinc with 2 mg copper should be used daily in combination with 500 mg of vitamin C, 400 IU of vitamin E, and 15 mg of beta-carotene.14 Table 3 lists common oral zinc preparations.
Table 3 Common Oral Zinc Preparations
Common Oral Zinc Preparations
|Zinc preparation||Elemental zinc (mg)|
Zinc acetate, 30% zinc, 25 mg
Zinc acetate, 30% zinc, 50 mg
Zinc gluconate, 14.3% zinc, 50 mg
Zinc gluconate, 14.3% zinc, 100 mg
Zinc sulfate, 23% zinc, 110 mg
Zinc sulfate, 23% zinc, 220 mg
Zinc oxide, 80% zinc, 100 mg
note: The standard ingredient labels for dietary supplements provide the name of the form of zinc in the product (e.g., zinc [as zinc sulfate]) and the amount of elemental zinc in milligrams.
Despite zinc's many essential roles in human physiology, no robust data support zinc supplementation alone for persons with a normal zinc status. However, zinc in combination with antioxidants may be modestly effective in slowing the progression of age-related macular degeneration. In children living in developing areas of the world, zinc supplementation may be an effective preventive measure for diarrhea and URI, and an adjunct treatment for diarrhea. Zinc has been shown to be an effective treatment for Wilson disease. No consistent benefit of zinc has been found for treatment of URI, wound healing, or HIV. Ongoing zinc supplementation up to the tolerable upper intake level is generally safe. Higher doses should be limited to short-term use because of an increased risk of gastrointestinal adverse effects, copper deficiency, anemia, and genitourinary complications.
1. King JC. Zinc In: Shils ME, Shike M, eds. Modern Nutrition in Health and Disease. 10th ed Philadelphia, Pa: Lippincott Williams & Wilkins; 2006: 271–285.
2. Institute of Medicine (U.S.). DRI: Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press; 2001.
3. Microminerals In: Groff JL, Gropper SA, eds. Advanced Nutrition and Human Metabolism. 3rd ed Belmont, Calif: West/Wadsworth; 2000:401–470.
4. Timbo BB, Ross MP, McCarthy PV, Lin CT. Dietary supplements in a national survey: prevalence of use and reports of adverse events. J Am Diet Assoc. 2006;106(12):1966–1974.
5. Cousins RJ. Systemic transport of zinc. In: Mills CF. Zinc in Human Biology. New York, NY: :Springer-Verlag; 198979–93.
6. Iwata M, Takebayashi T, Ohta H, Alcalde RE, Itano Y, Matsumura T. Zinc accumulation and metallothionein gene expression in the proliferating epidermis during wound healing in mouse skin. Histochem Cell Biol. 1999;112(4):283–290.
7. Cario E, Jung S, Harder D'Heureuse J, et al. Effects of exogenous zinc supplementation on intestinal epithelial repair in vitro. Eur J Clin Invest. 2000;30(5):419–428.
8. Mocchegiani E, Santarelli L, Muzzioli M, Fabris N. Reversibility of the thymic involution and of age-related peripheral immune dysfunctions by zinc supplementation in old mice. Int J Immunopharmacol. 1995;17(9):703–718.
9. Grahn BH, Paterson PG, Gottschall-Pass KT, Zhang Z. Zinc and the eye. J Am Coll Nutr. 2001;20(2 suppl):106–118.
10. World Health Organization. The World Health Report, 2002: Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: :World Health Organization; 2002.
11. Brown KH, Peerson JM, Rivera J, Allen LH. Effect of supplemental zinc on the growth and serum zinc concentrations of prepubertal children: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2002;75(6):1062–1071.
12. Lukacik M, Thomas RL, Aranda JV. A meta-analysis of the effects of oral zinc in the treatment of acute and persistent diarrhea. Pediatrics. 2008;121(2):326–336.
13. Aggarwal R, Sentz J, Miller MA. Role of zinc administration in prevention of childhood diarrhea and respiratory illnesses: a meta-analysis. Pediatrics. 2007;119(6):1120–1130.
14. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 [published correction appears in Arch Ophthalmol. 2008;126(9):1251]. Arch Ophthalmol. 2001;119(10):1417–1436.
15. Evans JR. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev. 2006;(2):CD000254.
16. Johnson AR, Munoz A, Gottlieb JL, Jarrard DF. High dose zinc increases hospital admissions due to genitourinary complications. J Urol. 2007;177(2):639–643.
17. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994;330(15):1029–1035.
18. Evans JR, Henshaw K. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database Syst Rev. 2008;(1):CD000253.
19. Chong EW, Wong TY, Kreis AJ, Simpson JA, Guymer RH. Dietary anti-oxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. BMJ. 2007;335(7623):755.
20. Tan JS, Wang JJ, Flood V, Rochtchina E, Smith W, Mitchell P. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology. 2008;115(2):334–341.
21. Jackson JL, Lesho E, Peterson C. Zinc and the common cold: a meta-analysis revisited. J Nutr. 2000;130(5S suppl):1512S–1515S.
22. Prasad AS, Fitzgerald JT, Bao B, Beck FW, Chandrasekar PH. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000;133(4):245–252.
23. Turner RB, Cetnarowski WE. Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds. Clin Infect Dis. 2000;31(5):1202–1208.
24. Prasad AS, Beck FW, Bao B, et al. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr. 2007;85(3):837–844.
25. Mossad SB. Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults. QJM. 2003;96(1):35–43.
26. Kurugöl Z, Akilli M, Bayram N, Koturoglu G. The prophylactic and therapeutic effectiveness of zinc sulphate on common cold in children. Acta Paediatr. 2006;95(10):1175–1181.
27. Macknin ML, Piedmonte M, Calendine C, Janosky J, Wald E. Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial. JAMA. 1998;279(24):1962–1967.
28. Rojas AI, Phillips TJ. Patients with chronic leg ulcers show diminished levels of vitamins A and E, carotenes, and zinc. Dermatol Surg. 1999;25(8):601–604.
29. Wananukul S, Limpongsanuruk W, Singalavanija S, Wisuthsarewong W. Comparison of dexpanthenol and zinc oxide ointment with ointment base in the treatment of irritant diaper dermatitis from diarrhea: a multicenter study. J Med Assoc Thai. 2006;89(10):1654–1658.
30. Wilkinson EA, Hawke CI. Does oral zinc aid the healing of chronic leg ulcers? A systematic literature review. Arch Dermatol. 1998;134(12):1556–1560.
31. Agren MS, Ostenfeld U, Kallehave F, et al. A randomized, double-blind, placebo-controlled multicenter trial evaluating topical zinc oxide for acute open wounds following pilonidal disease excision. Wound Repair Regen. 2006;14(5):526–535.
32. Jones CY, Tang AM, Forrester JE, et al. Micronutrient levels and HIV disease status in HIV-infected patients on highly active antiretroviral therapy in the Nutrition for Healthy Living cohort. J Acquir Immune Defic Syndr. 2006;43(4):475–482.
33. Bobat R, Coovadia H, Stephen C, et al. Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial. Lancet. 2005;366(9500):1862–1867.
34. Villamor E, Aboud S, Koulinska IN, et al. Zinc supplementation to HIV-1-infected pregnant women: effects on maternal anthropometry, viral load, and early mother-to-child transmission. Eur J Clin Nutr. 2006;60(7):862–869.
35. Czlonkowska A, Gajda J, Rodo M. Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate. J Neurol. 1996;243(3):269–273.
36. Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med. 1998;132(4):264–278.
37. Dreno B, Moyse D, Alirezai M, et al. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology. 2001;203(2):135–140.
38. Fosmire GJ. Zinc toxicity. Am J Clin Nutr. 1990;51(2):225–227.
39. Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willet WC, Giovannucci EL. Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst. 2003;95(13):1004–1007.
40. Walravens PA, Hambidge KM, Koepfer DM. Zinc supplementation in infants with a nutritional pattern of failure to thrive: a double-blind, controlled study. Pediatrics. 1989;83(4):532–538.
41. Nutritional disorders. In: Beers MH, ed. The Merck Manual of Diagnosis and Therapy. 18th ed. Whitehouse Station, N.J.: Merck Research Laboratories; 2006: 55.
Members of various family medicine departments develop articles for “Complementary and Alternative Medicine.” This is one in a series coordinated by Sumi Sexton, MD, and Benjamin Kligler, MD, MPH.
Copyright © 2009 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions